Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Digestive Care
Digestive Care
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Pertzye
Pancrelipase
2012-05-17
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pancrelipase
pancreatic neoplasms
,
exocrine pancreatic insufficiency
Aspartame
iron-deficiency anemia
,
iron deficiencies
,
malnutrition
Nadide
myelodysplastic syndromes
,
myeloid leukemia acute
,
hematologic neoplasms
,
recurrence
,
non-hodgkin lymphoma
,
lymphoma
,
preleukemia
,
acute disease
,
syndrome
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
hepatitis
,
chronic hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
hepacivirus
,
chronic hepatitis b
Pancreatin
pancreatic neoplasms
,
exocrine pancreatic insufficiency
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use